Recent research sheds light on the significant challenges that older adults face when battling respiratory illnesses like flu and COVID-19. The study highlights the role of age-related inflammation in exacerbating symptoms, sometimes leading to severe health complications.
Aging Lung Cells and Inflammation
Researchers have turned their attention to fibroblasts, the structural cells essential for maintaining lung tissue, to understand the changes that occur in older lungs. Experiments conducted on young mice revealed that activating a stress signal associated with aging led to the formation of clusters of inflamed cells, particularly those identified by the GZMK gene, which has been linked to severe COVID-19 cases. This discovery opens the door for potential treatments aimed at targeting these cells to disrupt the cycle of chronic inflammation, known as inflammaging.
Dr. Tien Peng, a professor of Medicine at UCSF and a senior author of the study published in Immunity, expressed surprise at the collaboration between lung fibroblasts and immune cells in driving this inflammatory response. "This suggests new avenues for intervention before patients experience severe inflammation requiring intubation," he noted.
Fibroblasts and the NF-kB Pathway
Fibroblasts are crucial for ensuring the stability and functionality of the lungs' airways and air sacs. However, they can also contribute to inflammation in diseases like COPD. The research team investigated the NF-kB pathway, known for its association with aging-related diseases. Upon activation, fibroblasts prompted macrophages in the lungs to initiate an immune response, attracting additional immune cells, including those marked by GZMK.
While these GZMK cells were ineffective in combating infections, they still inflicted damage on lung tissue. The study found that young mice developed severe symptoms upon infection, mirroring the responses typically observed in older adults. Notably, when researchers genetically removed the GZMK cells, the mice exhibited improved tolerance to the infection, indicating that aging lung tissue may significantly drive harmful inflammation.
Additionally, the team analyzed lung tissue from older patients who had been hospitalized with COVID-related acute respiratory distress syndrome (ARDS). The samples revealed similar clusters of inflamed cells as seen in the mice, with a higher prevalence in patients experiencing more severe illness. "During the COVID pandemic, we observed that our most vulnerable patients continued to suffer from severe lung inflammation even after the infection had cleared," Dr. Peng remarked. "This dysfunction between lung and immune cells presents a promising target for new therapeutic strategies."